To obtain an overview of the gene expression profile in the development of fulminant hepatic failure, cDNA samples were prepared for FHF mouse model (6 h after the intraperitoneal injections of GalN/LPS, Figure 1-A1) and normal control mouse (Figure 1-B1), and then sequenced by using the Illumina sequencing platform. This evidence concerns the gene GAL and Fulminant hepatic failure.